Newsroom

December 08, 2017

In a randomized, Phase III trial led by researchers at The University of Texas MD Anderson Cancer Center, the PARP inhibitor...

Novel regulation of gene expression in brain tumors identified

December 06, 2017

Study results revealed previously unknown interplay between two key enzymes and a novel understanding of how brain cancer tumors form...

Ribociclib extends progression-free survival in...

December 06, 2017

The addition of ribociclib, an inhibitor of the cell cycle, to standard hormone therapy significantly improved progression-free...

MD Anderson to present key drug study findings for multiple...

December 01, 2017

Researchers at The University of Texas MD Anderson Cancer Center will present their latest findings involving drug treatments for...

Peter WT Pisters, M.D., begins tenure as president of...

December 01, 2017

The University of Texas MD Anderson Cancer Center today welcomes Peter WT Pisters, M.D., as its fifth full-time president in the...

MD Anderson applauds court-ordered corrective statements...

November 27, 2017

As an institution dedicated to ending cancer, The University of Texas MD Anderson Cancer Center is committed to promoting cancer...

Six researchers from MD Anderson elected as AAAS Fellows

November 20, 2017

In recognition of their contributions to basic, translational, and clinical research, six faculty members from The University of...

Quality of care for older Texas patients with colon cancer...

November 15, 2017

Research from The University of Texas MD Anderson Cancer Center finds adherence to surgical treatment guidelines has improved...

Seres Therapeutics, MD Anderson Cancer Center, and the Parker...

November 14, 2017

Seres Therapeutics, Inc., The University of Texas MD Anderson Cancer Center and the Parker Institute for Cancer Immunotherapy today...

Thousands support MD Anderson’s Boot Walk to End Cancer®

November 13, 2017

Thousands of patients, family members, volunteers, friends and employees of The University of Texas MD Anderson Cancer Center...

Seven leaders join MD Anderson Cancer Center Board of Visitors

November 08, 2017

The University of Texas MD Anderson Cancer Center Board of Visitors (BOV) welcomed seven new members at its annual meeting today. They...

Chronic stress hormones may promote resistance to EGFR...

November 08, 2017

Elevated levels of chronic stress hormones, such as those produced by psychological distress, may promote resistance to drugs commonly...

Circulating tumor cells associated with relapse in...

November 07, 2017

A study revealing a connection between circulating tumor cells (CTCs) and relapse in stage IV melanoma patients points to liquid...

MD Anderson’s Moon Shots Program celebrates five-year...

November 06, 2017

The University of Texas MD Anderson Cancer Center celebrates the five-year anniversary of its Moon Shots Program^™, a collaborative...

Bacteria in the gut modulates response to immunotherapy in...

November 02, 2017

Bacteria that live in the human digestive tract can influence how cancer responds to immunotherapy, opening a new avenue for research...

Sarah Ann Roder receives MD Anderson’s highest nursing honor

November 01, 2017

Sarah Ann Roder, a clinical nurse in the Gynecologic Oncology Outpatient Center at The University of Texas MD Anderson Cancer...

Baytown community launches Be Well^™ Baytown initiative led...

October 30, 2017

In an effort to improve public health and lower the risk of cancer, Baytown community organizations are partnering with The University...

Dream Team aims to intercept pancreatic cancer before it...

October 26, 2017

Deeply entrenched and mature by the time it’s found, pancreatic cancer is one of the hardest to defeat. A Dream Team assembled by...

MD Anderson Hosts A Conversation With a Living Legend^® with...

October 19, 2017

Houston philanthropist Rich Kinder, executive chairman of Kinder Morgan Inc., will join Houston-based NBC News correspondent Janet...

Drug yields high response rates for lung cancer patients...

October 17, 2017

A targeted therapy resurrected by the Moon Shots Program^™ at The University of Texas MD Anderson Cancer Center has produced...

V. Craig Jordan, Ph.D., elected to the National Academy of...

October 16, 2017

V. Craig Jordan, Ph.D., professor of Breast Medical Oncology, has been elected to the National Academy of Medicine for his discovery...

Cattlemen for Cancer Research to host annual auction Oct. 21

October 16, 2017

Cattlemen for Cancer Research (CCR) will hold its 19th annual auction Saturday, Oct. 21 at the Hills Prairie Livestock Auction...

MD Anderson team selected for national push to expand...

October 12, 2017

A major national effort to expand the reach of cancer immunotherapy to benefit more patients will draw upon the expertise of a team of...

MD Anderson expert to lead free Austin panel on Alzheimer’s...

October 10, 2017

The University of Texas MD Anderson Cancer Center and Belmont Village Senior Living will present a free panel discussion in Austin...

Registration open for Nov. 11 Boot Walk to End Cancer®

October 04, 2017

The University of Texas MD Anderson Cancer Center has opened registration for the second annual Boot Walk to End Cancer^®, Saturday,...

MD Anderson and BridgeBio Pharma launch Navire Pharma to...

October 04, 2017

The University of Texas MD Anderson Cancer Center and BridgeBio Pharma today announced the launch of Navire Pharma, a...

MD Anderson Cancer Center and Pfizer Oncology announce...

September 26, 2017

The University of Texas MD Anderson Cancer Center and Pfizer Inc. today announced that they have entered into a clinical...

Study shows diet and exercise improve treatment outcomes...

September 21, 2017

Diet and exercise may improve treatment outcomes in pediatric cancer patients, according to a study at The University of Texas MD...

Tibetan yoga practice may improve sleep quality for breast...

September 20, 2017

Participating in twice-weekly practice of Tibetan yoga may reduce sleep disturbances and improve sleep quality in breast cancer...

Researchers compose guidelines for handling CAR T cell side...

September 19, 2017

Immune-cell based therapies opening a new frontier for cancer treatment carry unique, potentially lethal side effects that provide a...

MD Anderson and Daiichi Sankyo enter research collaboration...

September 14, 2017

The University of Texas MD Anderson Cancer Center and Daiichi Sankyo Company, Limited today announced a multi-year collaboration...

MD Anderson Cancer Center to provide free skin cancer...

September 13, 2017

As the official cancer center of the PGA TOUR, The University of Texas MD Anderson Cancer Center will provide complimentary skin...

Rogers Award honors William Atkinson for Excellence in...

September 12, 2017

William Atkinson is the 2017 recipient of the Julie and Ben Rogers Award for Excellence in Administration at The University of Texas...

Following Hurricane Harvey, MD Anderson maintains...

September 08, 2017

Through dedicated teamwork, strategic planning and the support of its internal and external communities, The University of Texas MD...

Making Cancer History®: Free seminar returns to Atlanta

September 06, 2017

The University of Texas MD Anderson Cancer Center brings its signature Making Cancer History^® Seminar to Atlanta for the third time,...

MD Anderson receives $7.5 million in CPRIT funding for...

August 21, 2017

The University of Texas MD Anderson Cancer Center this week was awarded $7.5 million from the Cancer Prevention and Research Institute...

MD Anderson’s Keeling Center Open House set for April 21

August 21, 2017

The University of Texas MD Anderson Cancer Center’s Michale E. Keeling Center for Comparative Medicine and Research will open its...

Obituary for Charles Aubrey LeMaistre, M.D.

August 21, 2017

Charles Aubrey LeMaistre, M.D.

1924-2017

Charles Aubrey “Mickey” LeMaistre, M.D., beloved physician, father, trusted friend...

Former MD Anderson President Dr. Charles A. LeMaistre...

August 21, 2017

Charles Aubrey “Mickey” LeMaistre, M.D., past president of The University of Texas MD Anderson Cancer Center and a pioneering crusader...

A Conversation With a Living Legend^® honors international...

August 15, 2017

The 28th annual A Conversation With a Living Legend^® in Dallas, Sept. 14 at the Hilton Anatole, honors architect, artist and engineer...

Checkpoint inhibitors fire up different types of T cells to...

August 10, 2017

Cancer immunotherapies that block two different checkpoints on T cells launch immune attacks on cancer by expanding distinct types of...

MD Anderson ranked top cancer hospital in annual survey

August 07, 2017

The University of Texas MD Anderson Cancer Center again has ranked No. 1 for cancer care by U.S. News & World Report’s annual “Best...

Concurrent chemotherapy, proton therapy improves survival...

July 20, 2017

For patients with advanced, inoperable stage 3 lung cancer, concurrent chemotherapy and the specialized radiation treatment, proton...

Genetically enhanced, cord-blood derived immune cells...

July 13, 2017

Immune cells with a general knack for recognizing and killing many types of infected or abnormal cells also can be engineered to hunt...

Tumor-targeting drug shows potential for treating bone...

July 12, 2017

The treatment of osteosarcoma, the most common tumor of bone, is challenging. A study led by The University of Texas MD Anderson...

MD Anderson announces new leadership structure

June 29, 2017

The University of Texas MD Anderson Cancer Center today announced a new leadership structure designed to enhance teamwork and...

Study shows biomarkers can predict which ER-positive breast...

June 27, 2017

Two challenges in treating patients with estrogen-positive breast cancer (ER+) have been an inability to predict who will respond to...

MD Anderson UTHealth Graduate School receives $10.5 million gift

June 23, 2017

Just as he has changed the lives of people suffering from a devastating genetic disease, molecular endocrinologist John J. Kopchick,...

Making Cancer History® Seminar returns to Aspen

June 20, 2017

The University of Texas MD Anderson Cancer Center plans its 19th annual Making Cancer History^® seminar in Aspen, free and open to the...

MD Anderson and Convergent R.N.R. Ltd. establish alliance to...

June 12, 2017

The University of Texas MD Anderson Cancer Center and Convergent R.N.R. Ltd. (CRnR) today announced a collaboration to further develop...

Innovative therapy strategy for pancreatic cancer uses...

June 07, 2017

Genetic manipulation of exosomes, virus-sized particles released by all cells, may offer a new therapeutic approach to treating...

MD Anderson and Hitachi to collaborate in research for...

June 07, 2017

The University of Texas MD Anderson Cancer Center and Hitachi Healthcare Americas Corporation, have today announced that they have...

Higher gut bacteria diversity tied to slower metastatic...

June 05, 2017

The blend of bacteria in the digestive tract of metastatic melanoma patients is associated with disease progression or delay in...

Two combination therapies shrink melanoma brain metastases...

June 04, 2017

High response rates to a pair of combination therapies point to potentially new options for a group of metastatic melanoma patients...

Combination therapy targets genetic mutation found in many...

June 02, 2017

A study at The University of Texas MD Anderson Cancer Center has shown promise for effective treatment of therapy-resistant cancers...

Image-guided biopsies accurately identify breast cancer...

May 30, 2017

In a clinical feasibility trial conducted at The University of Texas MD Anderson Cancer Center, image-guided biopsies identified...

Study provides better understanding of how brain tumors...

May 25, 2017

All cancer tumors have one thing in common – they must feed themselves to grow and spread, a difficult feat since they are usually in...

San Diego Zoo Kids brings world of animals to MD Anderson...

May 24, 2017

The University of Texas MD Anderson Children’s Cancer Hospital today debuted San Diego Zoo Kids, a new television channel for patients...

Ellis Island Medal of Honor Presented to Ronald DePinho,...

May 18, 2017

Ronald DePinho, M.D., professor of biology and former president, The University of Texas MD Anderson Cancer Center, is among the...

HPV vaccine may reduce oral infections by as much as 88...

May 17, 2017

ABSTRACT: 6003 Researchers have found that the human papillomavirus (HPV) vaccine may reduce the rate of oral HPV infections in...

MD Anderson convenes global network of cancer-fighting...

May 08, 2017

More than 800 cancer doctors, nurses and scientists from all over the world will gather at The University of Texas MD Anderson Cancer...

Andrew Sabin Family Fellows to receive $100,000 in research...

May 08, 2017

The University of Texas MD Anderson Cancer Center named eight innovative researchers to the second annual class of Andrew Sabin Family...

American Dental Association and MD Anderson Announce...

May 04, 2017

The American Dental Association (ADA) and The University of Texas MD Anderson Cancer Center today announced a joint effort to improve...

MD Anderson names Ben Melson new chief financial officer

May 04, 2017

The University of Texas MD Anderson Cancer Center has announced that Ben Melson will become the institution’s senior vice president...

MD Anderson genetics expert Guillermina Lozano elected to...

May 03, 2017

Guillermina Lozano, Ph.D., chair of Genetics at The University of Texas MD Anderson Cancer Center, has been elected to the prestigious...

UT System hosts annual Eliminate Tobacco Use Summit

May 03, 2017

The University of Texas System convened its 2nd Annual Eliminate Tobacco Use Summit April 17-18 in Austin to enhance tobacco control...

Local restaurants and businesses bring prom to MD Anderson

April 24, 2017

The University of Texas MD Anderson Children’s Cancer Hospital joins Houston restaurants and businesses to host its second annual Prom...

Jim Allison named one of TIME’s 100 most influential people

April 20, 2017

The University of Texas MD Anderson Cancer Center Chair of Immunology Jim Allison, Ph.D., whose pivotal insight to attack cancer by...

Pathologic complete response to neoadjuvant therapy in...

April 19, 2017

Select breast cancer patients who achieved pathologic complete response (pCR) after chemotherapy may be able to avoid follow-up breast...

MD Anderson and Lion Biotechnologies announce strategic...

April 19, 2017

The University of Texas MD Anderson Cancer Center and Lion Biotechnologies, Inc., a biotechnology company developing novel cancer...

Making Cancer History®: Free seminar returns to Midland

April 06, 2017

The University of Texas MD Anderson Cancer Center brings its signature Making Cancer History^® Seminar to Midland, for the second time,...

MD Anderson, Oncora Medical team up to fight cancer with...

April 04, 2017

Oncora Medical, a precision radiation oncology software company, and The University of Texas MD Anderson Cancer Center, today...

Stand Up to Cancer innovation grant funds MD Anderson...

April 03, 2017

An Innovative Research Grant from Stand Up to Cancer will help a University of Texas MD Anderson Cancer Center physician scientist and...

Immunologic changes point to potential for clinical...

March 29, 2017

Immunologic changes observed in an early study of patients with metastatic renal cell carcinoma (MRCC) raised the possibility for a...

Protein identified as potential druggable target for...

March 28, 2017

A protein known as arginine methyltransferase 1 (PRMT1) may be a potential therapeutic target for pancreatic ductal adenocarcinoma...

Minority colorectal cancer patients report higher burden of...

March 27, 2017

A study of racial disparities in health-related quality of life of colorectal cancer patients revealed among several findings, that...

Study provides path for new immunotherapy approaches to...

March 27, 2017

Prostate cancer, notoriously resistant to immunotherapy due to its immunologically cool nature, triggers two pathways to chill an...

Jerry Jeff Walker to headline April 29 Polo on the Prairie...

March 21, 2017

The 31st annual Polo on the Prairie, a U.S. Polo Association-sanctioned event benefiting cancer research and patient care programs at...

MD Anderson expert to lead Dallas panels on Alzheimer’s...

March 20, 2017

The University of Texas MD Anderson Cancer Center brings Jim Ray, Ph.D., head of Neuroscience, to Dallas on Thursday, April 20, to...

Marshall E. Hicks named interim president of UT MD Anderson Cancer...

March 17, 2017

University of Texas System Chancellor William H. McRaven announced today the appointment of Marshall E. Hicks, M.D., as interim...

Advanced form of proton therapy shows promise for treating...

March 17, 2017

An advanced form of image-guided radiation therapy, known as intensity modulated proton therapy (IMPT), has shown early promise for...

MD Anderson celebrates the mission of Kick Butts Day

March 15, 2017

As an institution devoted to eliminating cancer, The University of Texas MD Anderson Cancer Center proudly supports the mission of...

Change in Leadership at MD Anderson

March 08, 2017

Ronald A. DePinho M.D., president of The University of Texas MD Anderson Cancer Center, has submitted a letter to Chancellor William...

Statement from The University of Texas System Chancellor William...

March 08, 2017

When Dr. Ron DePinho was named president of The University of Texas MD Anderson Cancer Center by the Board of Regents in 2011,&nbsp...

Functional brain training alleviates chemotherapy-induced...

March 03, 2017

A type of functional brain training known as neurofeedback shows promise in reducing symptoms of chemotherapy-induced nerve damage, or...

MD Anderson to provide skin cancer screenings, cancer...

March 02, 2017

Cancer prevention specialists from The University of Texas MD Anderson Cancer Center will provide skin cancer screenings free to the...

Monoclonal antibody drug superior to chemotherapy for...

March 01, 2017

A Phase III clinical trial involving 101 centers in 21 countries revealed the monoclonal antibody blinatumomab to be more effective...

Absent tumor-suppressors allow melanoma to thwart...

March 01, 2017

It’s what’s missing in the tumor genome, not what’s mutated, that thwarts treatment of metastatic melanoma with immune checkpoint...

MD Anderson study ties protein ‘reader’ ENL to common...

March 01, 2017

Anyone who uses an employee badge to enter a building may understand how a protein called ENL opens new possibilities for treating...

Two migration proteins boost predictive value of pancreatic...

February 28, 2017

Adding two blood-borne proteins associated with cancer cell migration increases the predictive ability of the current biomarker for...

Study reveals PGK1 enzyme as therapeutic target for...

February 23, 2017

Discovery of a dual role played by the enzyme phosphoglycerate kinase 1 (PGK1) may indicate a new therapeutic target for glioblastoma,...

Lung cancer cells susceptible to inhibitor treatment via...

February 22, 2017

Next-generation cyclin dependent kinase 2/9 (CDK2/9) inhibitors offer a novel way to treat lung cancer with minimal toxic side effects...

Gut bacteria associated with cancer immunotherapy response...

February 21, 2017

Melanoma patients’ response to a major form of immunotherapy is associated with the diversity and makeup of trillions of potential...

Hormonal maintenance therapy may improve survival in women...

February 21, 2017

For women with a rare subtype of epithelial ovarian or peritoneum cancer, known as low-grade serous carcinoma (LGSC), hormone...

MD Anderson receives $19.5 million in CPRIT funding for...

February 17, 2017

The University of Texas MD Anderson Cancer Center this week was awarded $19.5 million from the Cancer Prevention and Research...

More patients with early-stage breast cancer may be able to...

February 15, 2017

Women with early-stage breast cancer who had an intermediate risk recurrence score (RS) from a 21-gene expression assay had similar...

MD Anderson designated first Project ECHO superhub for...

February 10, 2017

Recognizing a critical need to address disparities in cancer care, The University of Texas MD Anderson Cancer Center has been...

Scientists identify aggressive pancreatic cancer cells and...

February 09, 2017

Researchers have identified a gatekeeper protein that prevents pancreatic cancer cells from transitioning into a particularly...

Breast cancer patients with dense breast tissue more likely...

February 07, 2017

Breast cancer patients with dense breast tissue have almost a two-fold increased risk of developing disease in the contralateral...

MD Anderson to present Making Cancer History^® Seminar in...

February 06, 2017

The University of Texas MD Anderson Cancer Center returns to Southern California this month with its Making Cancer History^® Seminar,...

Researchers identify ‘synthetic essentiality’ as novel...

February 06, 2017

A new method has been found for identifying therapeutic targets in cancers lacking specific key tumor suppressor genes. The process,...

MD Anderson supports World Cancer Day with allies around...

February 04, 2017

In honor of World Cancer Day on Feb. 4, The University of Texas MD Anderson Cancer Center calls for health care providers,...

Dr. Stephen Hahn joins MD Anderson senior leadership team

February 03, 2017

The University of Texas MD Anderson Cancer Center today announced the appointment of Stephen Hahn, M.D., to the senior leadership role...

MD Anderson and Guardant Health announce partnership to...

January 31, 2017

The University of Texas MD Anderson Cancer Center and Guardant Health today announced a multi-year partnership designed to accelerate...

MD Anderson welcomes FDA proposed rule to limit carcinogen...

January 23, 2017

The University of Texas MD Anderson Cancer Center fully supports the proposed rule released today by the U.S. Food and Drug...

‘Collateral’ lethality may offer new therapeutic approach...

January 18, 2017

Cancer cells often delete genes that normally suppress tumor formation. These deletions also may extend to neighboring genes, an event...

MD Anderson Submits Letter to the Editor of Wall Street Journal

January 17, 2017

Dear Editor:

A reduction in force is something no institution wants to do, and it was something we worked tirelessly to avoid at MD...

MD Anderson and Deerfield Management create Vescor LLC to...

January 11, 2017

Vescor LLC, a new company focused on discovery and development of autophagy targeted therapeutics for cancer treatment, has been...

MD Anderson and nation’s cancer centers jointly endorse...

January 11, 2017

As national vaccination rates for the human papillomavirus (HPV) remain low, The University of Texas MD Anderson Cancer Center has...

MD Anderson and EMD Serono enter three-year strategic...